Cargando…

Relations between approved platinum drugs and non-coding RNAs in mesothelioma

Malignant mesothelioma diseases feature an increasing risk due to their severe forms and their association with asbestos exposure. Platinum(II) complexes such as cisplatin and carboplatin are clinically approved for the therapy of mesothelioma often in combination with antimetabolites such as pemetr...

Descripción completa

Detalles Bibliográficos
Autor principal: Biersack, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260483/
https://www.ncbi.nlm.nih.gov/pubmed/30809599
http://dx.doi.org/10.1016/j.ncrna.2018.08.001